Home » NEW NONINVASIVE TREATMENT FOR UTERINE FIBROIDS REDUCES NEED FOR THE OVER 200,000 HYSTERECTOMIES PERFORMED EACH YEAR IN THE U.S.
NEW NONINVASIVE TREATMENT FOR UTERINE FIBROIDS REDUCES NEED FOR THE OVER 200,000 HYSTERECTOMIES PERFORMED EACH YEAR IN THE U.S.
Beverly Tower Imaging Center announced the offering of a revolutionary and completely noninvasive procedure to treat symptomatic uterine fibroids. SonoWave combines magnetic resonance imaging (MRI) with focused ultrasound to destroy the benign but often debilitating and painful tumors.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050106005461&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct